Coronary artery bypass surgery provides long-term results superior to percutaneous coronary intervention

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Historically, medical management was primary for coronary artery disease (CAD), with surgery as a secondary option.
• Percutaneous coronary intervention (PCI) has gained popularity as a minimally invasive primary treatment for CAD.
• Emerging evidence questions the long-term superiority of PCI over traditional surgical approaches.

Purpose of the Study:

• To analyze recent evidence comparing long-term outcomes of PCI and coronary artery bypass surgery (CABG).
• To identify patient subgroups who benefit more from surgical revascularization versus PCI.
• To provide recommendations for optimal treatment allocation in CAD management.

Main Methods:

• Review and analysis of recent clinical trials and registries.
• Comparative assessment of long-term prognostic benefits between PCI and CABG.
• Identification of patient characteristics influencing treatment outcomes.

Main Results:

• Coronary artery bypass surgery (CABG) demonstrates superior long-term prognostic benefits compared to percutaneous coronary intervention (PCI) in many patients with significant coronary artery disease (CAD).
• Patients with complex atherosclerotic lesions, multivessel disease, left main stem disease, left ventricular dysfunction, and diabetes mellitus experience greater benefits from CABG.
• PCI's role should be limited to patient groups where its superiority or equivalence to CABG is established.

Conclusions:

• Surgical revascularization (CABG) remains the preferred treatment for complex coronary artery disease (CAD) and specific patient profiles.
• Percutaneous coronary intervention (PCI) should be reserved for selected cases with proven efficacy compared to CABG.
• Multidisciplinary team decision-making is crucial for ensuring optimal, long-term effective therapy for all CAD patients.